The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Enginoev S.T.

Federal Center for Cardiovascular Surgery;
Astrakhan State Medical University

Chernov I.I.

Federal Center for Cardiovascular Surgery

Komarov R.N.

Sechenov First Moscow State Medical University

Sinelnikov Yu.S.

Sukhanov Federal Center for Cardiovascular Surgery

Semagin A.P.

Polyakov Samara Regional Clinical Cardiology Dispensary

Arutyunayan V.B.

Sukhanov Federal Center of Cardiovascular Surgery

Chragyan V.A.

Sukhanov Federal Center of Cardiovascular Surgery

Kadyraliyev B.K.

Sechenov First Moscow State Medical University

Pisaryuk A.S.

Peoples’ Friendship University of Russia

Ismailbaev A.M.

Sechenov First Moscow State Medical University

Kuznetsov D.V.

Polyakov Samara Regional Clinical Cardiology Dispensary

Zybin A.A.

Polyakov Samara Regional Clinical Cardiology Dispensary

Dzandukoeva P.Kh.

Astrakhan State Medical University

Tlisov B.M.

Sechenov First Moscow State Medical University

Abdurakhmanov A.A.

Astrakhan State Medical University

Tarasov D.G.

Federal Center for Cardiovascular Surgery;
Astrakhan State Medical University

Risk of infective endocarditis after aortic valve neocuspidization (Ozaki procedure): a multiple-center study

Authors:

Enginoev S.T., Chernov I.I., Komarov R.N., Sinelnikov Yu.S., Semagin A.P., Arutyunayan V.B., Chragyan V.A., Kadyraliyev B.K., Pisaryuk A.S., Ismailbaev A.M., Kuznetsov D.V., Zybin A.A., Dzandukoeva P.Kh., Tlisov B.M., Abdurakhmanov A.A., Tarasov D.G.

More about the authors

Read: 2084 times


To cite this article:

Enginoev ST, Chernov II, Komarov RN, et al. Risk of infective endocarditis after aortic valve neocuspidization (Ozaki procedure): a multiple-center study. Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(6):578‑585. (In Russ.)
https://doi.org/10.17116/kardio202215061578

References:

  1. Cahill TJ, Prendergast BD. Risk of infective endocarditis after left-sided surgical valve replacement. Eur Heart J. 2018;39:2676-2678. https://doi.org/10.1093/eurheartj/ehy143
  2. Østergaard L, Valeur N, Ihlemann N, Smerup MH, Bundgaard H, Gislason G, et al. Incidence and factors associated with infective endocarditis in patients undergoing left-sided heart valve replacement. Eur Heart J. 2018;39:2668-2675. https://doi.org/10.1093/eurheartj/ehy153
  3. Thornhill MH, Jones S, Prendergast B, Baddour LM, Chambers JB, Lockhart PB, et al. Quantifying infective endocarditis risk in patients with predisposing cardiac conditions. Eur Heart J. 2018;39:586-595.  https://doi.org/10.1093/eurheartj/ehx655
  4. Glaser N, Jackson V, Holzmann MJ, Franco-Cereceda A, Sartipy U. Prosthetic Valve Endocarditis After Surgical Aortic Valve Replacement. Circulation. 2017;136:329-331.  https://doi.org/10.1161/CIRCULATIONAHA.117.028783
  5. Østergaard L, Valeur N, Ihlemann N, Bundgaard H, Gislason G, Torp-Pedersen C, et al. Incidence of infective endocarditis among patients considered at high risk. Eur Heart J. 2018;39:623-629.  https://doi.org/10.1093/eurheartj/ehx682
  6. Bockeria LA. (ed.). Cardiovascular Surgery — 2019. M.: A.N. Bakulev National Medical Research Center of Cardiovascular Surgery; 2020. (In Russ.).
  7. Ozaki S, Kawase I, Yamashita H, Uchida S, Nozawa Y, Takatoh M, et al. A total of 404 cases of aortic valve reconstruction with glutaraldehyde-treated autologous pericardium. J Thorac Cardiovasc Surg. 2014;147:301-306.  https://doi.org/10.1016/j.jtcvs.2012.11.012
  8. Ozaki S, Kawase I, Yamashita H, Uchida S, Takatoh M, Kiyohara N. Midterm outcomes after aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium. J Thorac Cardiovasc Surg. 2018;155:2379-2387. https://doi.org/10.1016/j.jtcvs.2018.01.087
  9. Arutyunyan V, Chernov I, Komarov R, Sinelnikov Y, Kadyraliev B, Enginoev S, et al. Immediate outcomes of aortic valve neocuspidization with glutaraldehyde-treated autologous pericardium: A multicenter study. Brazilian J Cardiovasc Surg. 2020;35:241-248.  https://doi.org/10.21470/1678-9741-2020-0019
  10. Chernov II, Enginoev ST, Komarov RN, et al. Short-term outcomes of Ozaki procedure: a multicenter study. Russian Journal of Cardiology. 2020;25(S4):4157. (In Russ.). https://doi.org/10.15829/1560-4071-2020-4157
  11. Iida Y, Sawa S, Fujii S, Shimizu H. Aortic valve neocuspidization in patients under 65 years old. Gen Thorac Cardiovasc Surg. 2020;68:780-784.  https://doi.org/10.1007/s11748-020-01302-9
  12. Akiyama S, Iida Y, Shimura K, Fujii S, Shimizu H, Sawa S. Midterm outcome of aortic valve neocuspidization for aortic valve stenosis with small annulus. Gen Thorac Cardiovasc Surg. 2020;68:762-767.  https://doi.org/10.1007/s11748-020-01299-1
  13. Benedetto U, Sinha S, Dimagli A, Dixon L, Stoica S, Cocomello L, et al. Aortic valve neocuspidization with autologous pericardium in adult patients: UK experience and meta-analytic comparison with other aortic valve substitutes. Eur J Cardio-Thoracic Surg. 2021;60(1):34-36.  https://doi.org/10.1093/ejcts/ezaa472
  14. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European. Eur Heart J. 2015;36:3075-3128. https://doi.org/10.1093/eurheartj/ehv319
  15. Sá MP, Chernov I, Marchenko A, chagyan V, Komarov R, Askadinov M, et al. Aortic Valve Neocuspidization (Ozaki Procedure) in Patients with Small Aortic Annulus (≤21mm): A Multicenter Study. Struct Hear. 2020;4(5):413-419.  https://doi.org/10.1080/24748706.2020.1792595
  16. d’Arcy JL, Coffey S, Loudon MA, Kennedy A, Pearson-Stuttard J, Birks J, et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. Eur Heart J. 2016;37:3515-3522. https://doi.org/10.1093/eurheartj/ehw229
  17. Wang A, Athan E, Pappas PA, Fowler VGJ, Olaison L, Paré C et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297:1354-1361. https://doi.org/10.1001/jama.297.12.1354
  18. Prendergast BD, Tornos P. Surgery for infective endocarditis: who and when? Circulation. 2010;121:1141-1152. https://doi.org/10.1161/CIRCULATIONAHA.108.773598
  19. Hoen B, Alla F, Selton-Suty C, Béguinot I, Bouvet A, Briançon S, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA. 2002;288:75-81.  https://doi.org/10.1001/jama.288.1.75
  20. Tornos P, Iung B, Permanyer-Miralda G, Baron G, Delahaye F, Gohlke-Bärwolf C, et al. Infective endocarditis in Europe: lessons from the Euro heart survey. Heart. 2005;91:571-575.  https://doi.org/10.1136/hrt.2003.032128
  21. Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;40:3222-3232. https://doi.org/10.1093/eurheartj/ehz620
  22. Moiseev VS, Kobalava ZD, Pisaryuk AS et al. Infective endocarditis in Moscow General Hospital: Clinical characteristics and outcomes (single-center 7-year experience). Kardiologiya. 2018;58:66-75. (In Russ.). https://doi.org/10.18087/cardio.2018.12.10192
  23. Duran CM, Gallo R, Kumar N. Aortic valve replacement with autologous pericardium: surgical technique. J Card Surg. 1995;10:1-9.  https://doi.org/10.1111/j.1540-8191.1995.tb00582.x
  24. Reuthebuch O, Koechlin L, Schurr U, Grapow M, Fassl J, Eckstein FS. Aortic valve replacement using autologous pericardium: single centre experience with the Ozaki technique. Swiss Med Wkly. 2018;148:w14591. https://doi.org/10.4414/smw.2018.14591
  25. Komarov R, Kurasov N, Ismailbaev A, Tlisov B, Danachev A, Simonyan A, et al. Aortic homograft implantation after Ozaki procedure: Case report. Int J Surg Case Rep. 2021;81:105782. https://doi.org/10.1016/j.ijscr.2021.105782
  26. Arvay A, Lengyel M. Incidence and risk factors of prosthetic valve endocarditis. Eur J Cardio-Thoracic Surg Off J Eur Assoc Cardio-Thoracic Surg. 1988;2:340-346. 
  27. Poirer NC, Pelletier LC, Pellerin M, Carrier M. 15-year experience with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg. 1998;66:57-61.  https://doi.org/10.1016/s0003-4975(98)01110-2
  28. Geraci JE, Dale AJ, Mcgoon DC. Bacterial endocarditis and endarteritis following cardiac operations. Wis Med J. 1963;62:302-315. 
  29. Ivert TS, Dismukes WE, Cobbs CG, Blackstone EH, Kirklin JW, Bergdahl LA. Prosthetic valve endocarditis. Circulation. 1984;69:223-232.  https://doi.org/10.1161/01.cir.69.2.223
  30. Grover FL, Cohen DJ, Oprian C, Henderson WG, Sethi G, Hammermeister KE. Determinants of the occurrence of and survival from prosthetic valve endocarditis. Experience of the Veterans Affairs Cooperative Study on Valvular Heart Disease. J Thorac Cardiovasc Surg. 1994;108:207-214. 
  31. Steckelberg JM, Wilson WR. Risk factors for infective endocarditis. Infect Dis Clin orth Am. 1993;7:9-19. 
  32. Hyde JA, Darouiche RO, Costerton JW. Strategies for prophylaxis against prosthetic valve endocarditis: a review article. J Heart Valve Dis. 1998;7:316-326. 

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.